CYP2C19 Gpx StripAssay

Assay for the identification of cytochrome (CYP) 2C19 gene mutations
based on polymerase chain reaction (PCR) and reverse-hybridization.

CYP2C19, a member of the cytochrome P450 superfamily, is an important liver enzyme involved in the metabolism of xenobiotics in the body. Numerous drugs prescribed as platelet inhibitors (clopidogrel), anticonvulsants (diazepam, mephenytoin), antidepressants (citalopram, sertraline), proton pump inhibitors (omeprazole, pantoprazole), or for the treatment of malaria (proguanil) are substrates for CYP2C19. Patients with defective enzyme variants are at risk of developing severe adverse reactions due to drug accumulation and toxicity. Conversely, when formation of an active metabolite is essential for the action of a drug, these patients can exhibit diminished response to therapy compared to extensive metabolizers.

SPECIFICATIONS

  • CE-labelled complete kit – DNA extraction included
  • Simple protocol for complex diagnostic questions
  • No expensive lab equipement required
  • Manual or automated
  • Easy setting up and automatization with DYNABLOT equipement
  • ready to use reagents

Fill in the form

and ask
us anything about our products

After completion, Goffin Molecular Technologies will contact you as soon as possible.

Skip to toolbar